These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2200539)
1. N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance. Radich JP; Kopecky KJ; Willman CL; Weick J; Head D; Appelbaum F; Collins SJ Blood; 1990 Aug; 76(4):801-7. PubMed ID: 2200539 [TBL] [Abstract][Full Text] [Related]
2. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia. Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y Oncology; 1992; 49(2):114-22. PubMed ID: 1574246 [TBL] [Abstract][Full Text] [Related]
3. Analysis of KRAS and NRAS Gene Mutations in Arab Asian Children With Acute Leukemia: High Frequency of RAS Mutations in Acute Lymphoblastic Leukemia. Al-Kzayer LF; Sakashita K; Al-Jadiry MF; Al-Hadad SA; Ghali HH; Uyen le TN; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Sughayer MA; Rihani R; Madanat FF; Inoshita T; Kamata M; Koike K Pediatr Blood Cancer; 2015 Dec; 62(12):2157-61. PubMed ID: 26222068 [TBL] [Abstract][Full Text] [Related]
5. ras mutations in human leukemia and related disorders. Greenberger JS Int J Cell Cloning; 1989 Nov; 7(6):343-59. PubMed ID: 2681441 [TBL] [Abstract][Full Text] [Related]
6. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Ahuja HG; Foti A; Bar-Eli M; Cline MJ Blood; 1990 Apr; 75(8):1684-90. PubMed ID: 2183888 [TBL] [Abstract][Full Text] [Related]
7. RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group. Sano H; Shimada A; Taki T; Murata C; Park MJ; Sotomatsu M; Tabuchi K; Tawa A; Kobayashi R; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y Int J Hematol; 2012 May; 95(5):509-15. PubMed ID: 22407852 [TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Neubauer A; Dodge RK; George SL; Davey FR; Silver RT; Schiffer CA; Mayer RJ; Ball ED; Wurster-Hill D; Bloomfield CD Blood; 1994 Mar; 83(6):1603-11. PubMed ID: 8123851 [TBL] [Abstract][Full Text] [Related]
10. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia. Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347 [TBL] [Abstract][Full Text] [Related]
12. ras oncogene activation and occupational exposures in acute myeloid leukemia. Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344 [TBL] [Abstract][Full Text] [Related]
13. RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia. Hirsch-Ginsberg C; LeMaistre AC; Kantarjian H; Talpaz M; Cork A; Freireich EJ; Trujillo JM; Lee MS; Stass SA Blood; 1990 Sep; 76(6):1214-9. PubMed ID: 2205309 [TBL] [Abstract][Full Text] [Related]